Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1999;58:541-545; doi:10.1136/ard.58.9.541
Copyright © 1999 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 1999;58:541-545 ( September )

Extended report

Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis Erik J Giltaya, Dirkjan van Schaardenburgd, Louis J G Goorena, Piet J Kostensec, Ben A C Dijkmansb

a Institute of Endocrinology, Reproduction and Metabolism, b Department of Rheumatology, c Department of Clinical Epidemiology and Biostatistics, d University Hospital Vrije Universiteit, Amsterdam, the Netherlands Department of Rheumatology, Jan van Breemen Institute, Amsterdam, the Netherlands

Correspondence to: Dr E J Giltay, Department of Endocrinology/Division of Andrology, University Hospital Vrije Universiteit, PO Box 7057, 1007 MB, Amsterdam, the Netherlands.

Accepted for publication 12 April 1999

OBJECTIVES---There is a lack of unanimity about (increased) serum levels of creatine kinase (CK) in patients with ankylosing spondylitis (AS), perhaps because of the inclusion of inappropriate controls. Therefore, serum levels of biochemical markers of muscle origin were assessed in AS patients compared with controls.
METHODS---In a comparative study serum levels of sarcoplasmic proteins indicating muscle cell leakage, creatinine, and C reactive protein (CRP) were measured. Fifty eight AS patients with a mean disease duration of 22 (SD 11) years and 58 age and sex matched controls (without back complaints) were included.
RESULTS---Lower serum levels in AS patients compared with controls were found for CK (mean (SD): 46 (21) v 76 (44) IU/l; p<0.001), aldolase (0.43 (0.36) v 0.58 (0.32) IU/l; p=0.001), creatinine (91 (13) v 96 (11) µmol/l; p=0.02), alanine aminotransferase (2.8 (1.5) v 4.1 (2.9) IU/l; p=0.001) and aspartate aminotransferase (7.0 (2.7) v 8.4 (3.5) IU/l; p=0.02). Also the lean body mass, as estimated by a formula using height, weight, age and sex, showed lower values in patients versus controls (56 (9) v 59 (9) kg; p=0.004), but creatinine clearance (by Cockcroft and Gault formula) was not different (p=0.48). Partial correlation coefficients adjusted for age and sex showed that CRP levels correlated negatively with CK and aldolase levels in AS patients (r= -0.48, p<0.001 and r= -0.37, p=0.005, respectively).
CONCLUSION---Serum levels of biochemical markers of muscle origin were lower in AS patients compared with controls. Patients with active AS, as reflected by high CRP levels, may have an increased protein degradation, predominantly in skeletal muscle.


© 1999 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Marcora, S., Casanova, F., Williams, E., Jones, J., Elamanchi, R., Lemmey, A. (2006). Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis. Rheumatology (Oxford) 45: 1385-1388 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs